RBA Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$248K Buy
+949
New +$243K 0.08% 100
2023
Q2
– Sell
-3,053
Closed -$486K – 91
2023
Q1
$486K Sell
3,053
-18,808
-86% -$2.88M 0.24% 60
2022
Q4
$3.53M Buy
21,861
+394
+2% +$60.4K 1.85% 28
2022
Q3
$2.88M Buy
21,467
+745
+4% +$107K 1.66% 32
2022
Q2
$3.17M Buy
20,722
+406
+2% +$62K 1.76% 31
2022
Q1
$3.29M Buy
20,316
+1,052
+5% +$153K 1.58% 34
2021
Q4
$2.61M Buy
19,264
+2,802
+17% +$331K 1.23% 38
2021
Q3
$1.78M Buy
16,462
+1,441
+10% +$165K 4.28% 10
2021
Q2
$1.69M Buy
15,021
+899
+6% +$101K 3.59% 12
2021
Q1
$1.53M Buy
14,122
+1,031
+8% +$110K 1.3% 33
2020
Q4
$1.4M Buy
13,091
+4,516
+53% +$434K 0.85% 51
2020
Q3
$751K Buy
8,575
+3,487
+69% +$328K 0.51% 63
2020
Q2
$500K Buy
+5,088
New +$448K 0.36% 73

Other funds holding ABBV

RBA Wealth Management's ABBV Position: Q3 2026 in Review

RBA Wealth Management opened a new position in AbbVie (ABBV) in Q3 2026: 949 shares worth $248K. The stake represents 0.08% of the portfolio and ranks #100 among its holdings. This is a return to the name: RBA Wealth Management previously reported a position in ABBV as recently as Q1 2023.

RBA Wealth Management first reported a position in ABBV in Q2 2020 and has held it in 13 quarters since. The position peaked at $3.53M in Q4 2022. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • RBA Wealth Management held 949 shares of AbbVie worth $248K as of Q3 2026.
  • AbbVie was a new RBA Wealth Management position in Q3 2026.
  • AbbVie made up 0.08% of RBA Wealth Management's portfolio in Q3 2026, its #100 holding.
  • RBA Wealth Management first reported a position in AbbVie in Q2 2020 and has held it in 13 quarters since.
  • RBA Wealth Management's AbbVie position peaked at $3.53M in Q4 2022.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on RBA Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.